Cost-effectiveness of strategies to increase screening coverage for cervical cancer in Spain: the CRIVERVA study
Autor/a
Trapero-Bertran, Marta
Acera Perez, Amèlia
de Sanjose, Silvia
Manresa Domínguez, Josep Maria
Rodríguez Capriles, Diego
Rodríguez Martínez, Ana
Bonet Simó, Josep Maria
Sánchez Sánchez, Norman
Hidalgo Valls, Pablo
Díaz Sanchis, Mireia
Fecha de publicación
2017-02-06ISSN
1471-2458
Resumen
Background
The aim of the study is to carry out a cost-effectiveness analysis of three different interventions to promote the uptake of screening for cervical cancer in general practice in the county of Valles Occidental, Barcelona, Spain.
Methods
Women aged from 30 to 70 years (n = 15,965) were asked to attend a general practice to be screened. They were randomly allocated to one of four groups: no intervention group (NIG); one group where women received an invitation letter to participate in the screening (IG1); one group where women received an invitation letter and informative leaflet (IG2); and one group where women received an invitation letter, an informative leaflet and a phone call reminder (IG3). Clinical effectiveness was measured as the percentage increase in screening coverage. A cost-effectiveness analysis was performed from the perspective of the public health system with a time horizon of three to five years – the duration of the randomised controlled clinical trial. In addition, a deterministic sensitivity analysis was performed. Results are presented according to different age groups.
Results
The incremental cost-effectiveness ratio (ICER) for the most cost-effective intervention, IG1, compared with opportunistic screening was € 2.78 per 1% increase in the screening coverage. The age interval with the worst results in terms of efficiency was women aged < 40 years.
Conclusions
In a population like Catalonia, with around 2 million women aged 30 to 70 years and assuming that 40% of these women were not attending general practice to be screened for cervical cancer, the implementation of an intervention to increase screening coverage which consists of sending a letter would cost on average less than € 490 for every 1000 women.
Tipo de documento
Artículo
Versión del documento
Versión aceptada
Lengua
English
Materias (CDU)
338 - Situación económica. Política económica. Gestión, control y planificación de la economía. Producción. Servicios. Turismo. Precios
61 - Medicina
Palabras clave
Cost-eficàcia
Cost effectiveness
Càncer
Cancer
Cáncer
Páginas
8
Publicado por
BMC
Colección
17; 194
Publicado en
BMC Public Health
Citación
Trapero Bertran, Marta; Acera Pérez, Amelia; de Sanjosé, Silvia et al. «Cost-effectiveness of strategies to increase screening coverage for cervical cancer in Spain: the CRIVERVA study». BMC Public Health, 2017, vol. 17, art. 194. Disponible en: <https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-017-4115-0>. Fecha de acceso: 20 ene. 2020. DOI: 10.1186/s12889-017-4115-0
Número del acuerdo de la subvención
info:eu-repo/grantAgreement/EC/FP7/603019
Este ítem aparece en la(s) siguiente(s) colección(ones)
Derechos
http://creativecommons.org/licenses/by-nc-nd/4.0/
Excepto si se señala otra cosa, la licencia del ítem se describe como http://creativecommons.org/licenses/by-nc-nd/4.0/